pharmaceutical investing OncoMed Announces Second Quarter 2018 Financial Results and Operational Highlights
pharmaceutical investing OncoMed Announces Fourth Quarter and Full Year 2017 Financial Results and Operational Highlights
Alvopetro Announces Q3 2026 Dividend of US$0.12 Per Share and Supplementary Information on December 31, 2025 Prospective Resources
Skyharbour Partner Company Purecore Commences Data Compilation and Target Generation at The Yurchison Uranium Property